Relmada Therapeutics
RLMD
#8820
Rank
HK$0.72 B
Marketcap
HK$23.93
Share price
2.16%
Change (1 day)
9.63%
Change (1 year)

Revenue for Relmada Therapeutics (RLMD)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Relmada Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2017 N/A
2016 N/A
2015 N/A
2013 HK$0.03 M-52.11%
2012 HK$0.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$4.75 BN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$24.39 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA